Birdwatch Archive

Birdwatch Note

2023-07-15 14:36:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

「日本人が世界の医薬品総額の40%を消費してる」という主張は誤りです。 第一三共がHP上で引用するIQVIA社のレポートによれば、世界で最も医薬品の売上が多いのはアメリカです。割合にして世界全体の40%を占めています。 日本における売上は約9.4兆円で、割合にして約6%程度に過ぎません。 https://www.daiichisankyo.co.jp/investors/individual/pharmaceutical/

Written by 4AF65FF2DB01B96AABBC60EBBFA4EF07A85C93C5A30015E20C5D133CAD1A10DE
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1680102990710177793

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1680224705427677184
  • noteId - 1680224705427677184
  • participantId -
  • noteAuthorParticipantId - 4AF65FF2DB01B96AABBC60EBBFA4EF07A85C93C5A30015E20C5D133CAD1A10DE Participant Details
  • createdAtMillis - 1689431761496
  • tweetId - 1680102990710177793
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 「日本人が世界の医薬品総額の40%を消費してる」という主張は誤りです。 第一三共がHP上で引用するIQVIA社のレポートによれば、世界で最も医薬品の売上が多いのはアメリカです。割合にして世界全体の40%を占めています。 日本における売上は約9.4兆円で、割合にして約6%程度に過ぎません。 https://www.daiichisankyo.co.jp/investors/individual/pharmaceutical/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-07-15 14:36:01 UTC
(1689431761496)
2023-07-15 20:11:02 UTC
(1689451862002)
CURRENTLY_RATED_HELPFUL 2023-07-16 02:10:12 UTC
(1689473412046)
CURRENTLY_RATED_HELPFUL 2023-07-15 20:11:02 UTC
(1689451862002)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2023-07-15 18:57:07 -0500 Rating Details
2023-07-15 18:12:40 -0500 Rating Details
2023-07-15 18:06:57 -0500 Rating Details
2023-07-15 17:41:18 -0500 Rating Details
2023-07-15 17:38:54 -0500 Rating Details
2023-07-15 17:37:33 -0500 Rating Details
2023-07-15 17:18:29 -0500 Rating Details
2023-07-15 16:36:56 -0500 Rating Details
2023-07-15 16:23:31 -0500 Rating Details
2023-07-15 16:19:23 -0500 Rating Details
2023-07-15 16:16:31 -0500 Rating Details
2023-07-15 16:16:11 -0500 Rating Details
2023-07-15 16:02:43 -0500 Rating Details
2023-07-15 15:55:11 -0500 Rating Details
2023-07-15 15:35:23 -0500 Rating Details
2023-07-15 15:32:13 -0500 Rating Details
2023-07-15 14:44:15 -0500 Rating Details
2023-07-15 13:15:33 -0500 Rating Details
2023-07-15 13:00:21 -0500 Rating Details
2023-07-15 12:31:57 -0500 Rating Details
2023-07-15 12:24:39 -0500 Rating Details
2023-07-15 12:16:03 -0500 Rating Details
2023-07-15 12:05:49 -0500 Rating Details
2023-07-15 11:54:47 -0500 Rating Details
2023-07-15 11:42:29 -0500 Rating Details
2023-07-15 11:21:43 -0500 Rating Details
2023-07-15 10:54:53 -0500 Rating Details
2023-07-15 10:41:04 -0500 Rating Details
2023-07-15 10:23:48 -0500 Rating Details
2023-07-15 10:14:35 -0500 Rating Details
2023-07-15 10:13:14 -0500 Rating Details
2023-07-15 10:00:07 -0500 Rating Details
2023-07-15 09:59:06 -0500 Rating Details
2023-07-15 09:49:59 -0500 Rating Details
2023-07-15 09:46:00 -0500 Rating Details
2023-07-15 20:39:41 -0500 Rating Details
2023-07-15 17:39:43 -0500 Rating Details
2023-07-15 16:20:53 -0500 Rating Details
2023-07-15 17:35:23 -0500 Rating Details
2023-07-15 17:16:53 -0500 Rating Details
2023-07-15 17:20:05 -0500 Rating Details